Dr. Isaac Yi Alsallamin, MD

Dr. Alsallamin practices at University Hospitals Cleveland Medical Center in Cleveland, Ohio, part of University Hospitals Health System.

Dr. Alsallamin's NPI, 1598310393, was assigned on August 8, 2019. Dr. Alsallamin holds Ohio license 57.248004.

Dr. Alsallamin's primary practice is University Hospitals Cleveland Medical Center, at 11100 Euclid Avenue, Cleveland, OH 44106 in Cuyahoga County. The practice phone is (216) 844-1000.

Dr. Alsallamin's primary practice is University Hospitals Cleveland Medical Center in Cleveland, Ohio, part of University Hospitals Health System. Dr. Alsallamin is also affiliated with University Hospitals St. John Medical Center. The medical group on file is University Hospitals Medical Practices. Dmand AI also links Dr. Alsallamin to 1 more hospital and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Alsallamin practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Alsallamin's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Alsallamin is licensed in Ohio.

CMS data shows 290 Medicare services from Dr. Alsallamin across 5 procedure codes in 2024, for 146 Medicare patients. Medicare paid $19,809 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 146 Medicare patients who saw Dr. Alsallamin in 2024. The largest group is 65 to 74, with 41 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 25% are also on Medicaid. Their average risk score is 2.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Alsallamin's median patient age at 70, with 54% women.

In 2024, Dr. Alsallamin wrote 171 Medicare Part D claims for 55 patients. 81% of them were for generic drugs. CMS names the drug for 14 of them, across 1 drug with 11 or more claims each, at $42 in total drug cost. In 2023, CMS named 176 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Alsallamin for performance year 2024, reported as part of a group. Dr. Alsallamin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 11 papers to Dr. Alsallamin, published from 2022 to 2024. 2022 was the busiest year, with 6. Dr. Alsallamin has published most often in Cureus. Dr. Alsallamin's most frequent co-authors are Ameed Mohammad Mahmoud Bawwab, Afnan M.i Alsallamin and Deema Chakhachiro.

CMS Open Payments shows 10 general payments to Dr. Alsallamin from 3 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 100% of the total. Medtronic, Inc. paid the most, $152.